FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Antonio M. Rabasco-Alvarez

Research Profile

Occupations

Concepts & Ideas

Chemicals & Drugs

Procedures

Objects

Microspheres

Living Beings

Phenomena

Physicochemical Phenomenon

Devices

Drug Delivery Systems

Co-author Network

Publications

TOP 3
Sheila Villasmil-Sánchez; Antonio M. Rabasco-Alvarez; Marisa L González-Rodríguez
Thermal and 31P-NMR studies to elucidate sumatriptan succinate entrapment behavior in phosphatidylcholine/cholesterol liposomes. Comparative 31P-NMR analysis on negatively and positively-charged liposomes.
M J Cózar-Bernal; Antonio M. Rabasco-Alvarez; Marisa L González-Rodríguez
Development and validation of a high performance chromatographic method for determining sumatriptan in niosomes.
Marisa L González-Rodríguez; Imane Mouram; Ma Jose Cózar-Bernal; Sheila Villasmil; Antonio M. Rabasco-Alvarez
Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Antonio M. Rabasco-Alvarez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sheila Villasmil-Sánchez; Antonio M. Rabasco-Alvarez; Marisa L González-Rodríguez
Thermal and 31P-NMR studies to elucidate sumatriptan succinate entrapment behavior in phosphatidylcholine/cholesterol liposomes. Comparative 31P-NMR analysis on negatively and positively-charged liposomes.
Colloids and surfaces. B, Biointerfaces 2013;105():14-23.
2013: M J Cózar-Bernal; Antonio M. Rabasco-Alvarez; Marisa L González-Rodríguez
Development and validation of a high performance chromatographic method for determining sumatriptan in niosomes.
Journal of pharmaceutical and biomedical analysis 2013;72():251-60.
2012: Marisa L González-Rodríguez; Imane Mouram; Ma Jose Cózar-Bernal; Sheila Villasmil; Antonio M. Rabasco-Alvarez
Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery.
Journal of pharmaceutical sciences 2012;101(10):3845-63.
2012: J M López-Cacho; Antonio M. Rabasco-Alvarez; B Talero; Pedro L González-R; Marisa L González-Rodríguez
Robust optimization of alginate-Carbopol 940 bead formulations.
TheScientificWorldJournal 2012;2012():605610.
2011: M L González-Rodríguez; Antonio M. Rabasco-Alvarez
Charged liposomes as carriers to enhance the permeation through the skin.
Expert opinion on drug delivery 2011;8(7):857-71.
2010: Adamo Fini; Cristina Cavallari; Gian Carlo Ceschel; Antonio M. Rabasco-Alvarez
Bimodal release of olanzapine from lipid microspheres.
Journal of pharmaceutical sciences 2010;99(10):4251-60.
2010: Francesca Maestrelli; Marisa L González-Rodríguez; Antonio M. Rabasco-Alvarez; Carla Ghelardini; Paola Mura
New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics.
International journal of pharmaceutics 2010;395(1-2):222-31.
2009: Francesca Maestrelli; Gaetano Capasso; Marisa L González-Rodríguez; Antonio M. Rabasco-Alvarez; Carla Ghelardini; Paola Mura
Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes.
Journal of liposome research 2009;19(4):253-60.
2008: S Salas; B Talero; Antonio M. Rabasco-Alvarez; Marisa L González-Rodríguez
Development and validation of a reverse-phase liquid chromatographic method for the assay of lidocaine hydrochloride in alginate-Gantrez microspheres.
Journal of pharmaceutical and biomedical analysis 2008;47(3):501-7.
2007: Paola Mura; Francesca Maestrelli; Marisa L González-Rodríguez; Ilaria Michelacci; Carla Ghelardini; Antonio M. Rabasco-Alvarez
Development, characterization and in vivo evaluation of benzocaine-loaded liposomes.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;67(1):86-95.
2007: Marisa L González-Rodríguez; L B Barros; J Palma; P L González-Rodríguez; Antonio M. Rabasco-Alvarez
Application of statistical experimental design to study the formulation variables influencing the coating process of lidocaine liposomes.
International journal of pharmaceutics 2007;337(1-2):336-45.
2006: Francesca Maestrelli; Marisa L González-Rodríguez; Antonio M. Rabasco-Alvarez; Paola Mura
Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
International journal of pharmaceutics 2006;312(1-2):53-60.
2005: Francesca Maestrelli; Marisa L González-Rodríguez; Antonio M. Rabasco-Alvarez; Paola Mura
Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
International journal of pharmaceutics 2005;298(1):55-67.
2005: J M López-Pinto; Marisa L González-Rodríguez; Antonio M. Rabasco-Alvarez
Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes.
International journal of pharmaceutics 2005;298(1):1-12.
2005: Adamo Fini; José R Moyano; Juan M Ginés; José I Perez-Martinez; Antonio M. Rabasco-Alvarez
Diclofenac salts, II. Solid dispersions in PEG6000 and Gelucire 50/13.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;60(1):99-111.
2005: Cristina Cavallari; Beatrice Albertini; Lorenzo Rodriguez; Antonio M. Rabasco-Alvarez; Adamo Fini
Release of indomethacin from ultrasound dry granules containing lactose-based excipients.
Journal of controlled release : official journal of the Controlled Release Society 2005;102(1):39-47.
2005: isabella orienti; Guendalina Zuccari; Adamo Fini; Antonio M. Rabasco-Alvarez; Roberta Carosio; Lizzia Raffaghello; Paolo G Montaldo
Modified doxorubicin for improved encapsulation in PVA polymeric micelles.
Drug delivery 2005;12(1):15-20.
2004: Marzia Cirri; Paola Mura; Antonio M. Rabasco-Alvarez; Juan M Ginés; José R Moyano; M L Gònzalez-Rodrìguez
Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers.
Drug development and industrial pharmacy 2004;30(1):65-74.
2003: José R Moyano; Tiziana Ventriglia; Juan M Ginés; F Muñoz; Antonio M. Rabasco-Alvarez
Study of glimepiride-b-cyclodextrin complex.
Bollettino chimico farmaceutico 2003;142(9):390-5.
2003: Marisa L González-Rodríguez; Francesca Maestrelli; Paola Mura; Antonio M. Rabasco-Alvarez
In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2003;20(1):125-31.
2002: Carla Sánchez-Lafuente; Antonio M. Rabasco-Alvarez; Josefa Alvarez-Fuentes; Mercedes Fernández-Arévalo
Eudragit RS-PM and Ethocel 100 Premium: influence over the behavior of didanosine inert matrix system.
Farmaco (Società chimica italiana : 1989) 2002;57(8):649-56.
2002: Carla Sánchez-Lafuente; Sandra Furlanetto; Mercedes Fernández-Arévalo; Josefa Alvarez-Fuentes; Antonio M. Rabasco-Alvarez; Maria Teresa Faucci; Sergio Pinzauti; Paola Mura
Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design.
International journal of pharmaceutics 2002;237(1-2):107-18.
2002: Carla Sánchez-Lafuente; M Teresa Faucci; Mercedes Fernández-Arévalo; Josefa Alvarez-Fuentes; Antonio M. Rabasco-Alvarez; Paola Mura
Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers.
International journal of pharmaceutics 2002;234(1-2):213-21.
2002: Marisa L González-Rodríguez; Maria Angeles Holgado; Carla Sánchez-Lafuente; Antonio M. Rabasco-Alvarez; Adamo Fini
Alginate/chitosan particulate systems for sodium diclofenac release.
International journal of pharmaceutics 2002;232(1-2):225-34.
2001: Marisa L González-Rodríguez; José I Pérez-Martínez; S Merino; Adamo Fini; Antonio M. Rabasco-Alvarez
Channeling agent and drug release from a central core matrix tablet.
Drug development and industrial pharmacy 2001;27(5):439-46.
2001: Luz María Melgoza; Antonio M. Rabasco-Alvarez; H Sandoval; Isidoro Caraballo
Estimation of the percolation thresholds in dextromethorphan hydrobromide matrices.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;12(4):453-9.
1999: Adamo Fini; Giuseppe Fazio; Antonio M. Rabasco-Alvarez; M J Fernández-Hervás; Maria Angeles Holgado
Effect of the temperature on a hydrate diclofenac salt.
International journal of pharmaceutics 1999;181(1):95-106.
1999: Isidoro Caraballo; Luz María Melgoza; Josefa Alvarez-Fuentes; M C Soriano; Antonio M. Rabasco-Alvarez
Design of controlled release inert matrices of naltrexone hydrochloride based on percolation concepts.
International journal of pharmaceutics 1999;181(1):23-30.
1999: Paola Mura; E Adragna; Antonio M. Rabasco-Alvarez; José R Moyano; J I Pérez-Martìnez; M J Arias; Juan M Ginés
Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems.
Drug development and industrial pharmacy 1999;25(3):279-87.
1999: Anailien Boza; Isidoro Caraballo; Josefa Alvarez-Fuentes; Antonio M. Rabasco-Alvarez
Evaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodium.
Drug development and industrial pharmacy 1999;25(2):229-33.
1998: Isidoro Caraballo; Josefa Alvarez-Fuentes; Luz María Melgoza; Mónica Millán; Maria Angeles Holgado; Antonio M. Rabasco-Alvarez; Mercedes Fernández-Arévalo
Validation study of the conductometrical analysis. Application to the drug release studies from controlled release systems.
Journal of pharmaceutical and biomedical analysis 1998;18(1-2):281-5.
1998: Mónica Millán; Isidoro Caraballo; Antonio M. Rabasco-Alvarez
The role of the drug/excipient particle size ratio in the percolation model for tablets.
Pharmaceutical research 1998;15(2):216-20.
1997: José R Moyano; MJ Arias-Blanco; JM Gines; Antonio M. Rabasco-Alvarez; José I Pérez-Martínez; M Mor; Ferdinando Giordano
Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with beta-cyclodextrin.
Journal of pharmaceutical sciences 1997;86(1):72-5.
1996: M J Arias; J M Ginés; José R Moyano; Antonio M. Rabasco-Alvarez
Dissolution properties and in vivo behaviour of triamterene in solid dispersions with polyethylene glycols.
Pharmaceutica acta Helvetiae 1996;71(4):229-35.
1996: Adamo Fini; Giuseppe Fazio; M J Fernández-Hervás; Maria Angeles Holgado; Antonio M. Rabasco-Alvarez
Fractal analysis of sodium cholate particles.
Journal of pharmaceutical sciences 1996;85(9):971-5.
1996: Isidoro Caraballo; M Millan; Antonio M. Rabasco-Alvarez
Relationship between drug percolation threshold and particle size in matrix tablets.
Pharmaceutical research 1996;13(3):387-90.
1994: M J Arias; J M Gines; José R Moyano; M J Perez-Barrales; M T Vela; Antonio M. Rabasco-Alvarez
Improvement of the diuretic effect of triamterene via solid dispersion technique with PEG 4000.
European journal of drug metabolism and pharmacokinetics 1994;19(4):295-302.
1994: Isidoro Caraballo; M Fernandez-Arevalo; Maria Angeles Holgado; M T Vela; Antonio M. Rabasco-Alvarez
A rapid HPLC method for the quantification of tyrothricin, menthol, and benzocaine in pharmaceutical formulations.
Journal of pharmaceutical sciences 1994;83(8):1147-9.
1994: M J Arias; J M Gines; José R Moyano; Antonio M. Rabasco-Alvarez
The application of solid dispersion technique with D-mannitol to the improvement in oral absorption of triamterene.
Journal of drug targeting 1994;2(1):45-51.
1993: M J Lucero; J Vigo; Antonio M. Rabasco-Alvarez; J A Sanchez; F Martin
Protection by alpha-tocopherol against skin necrosis induced by doxorubicin hydrochloride.
Die Pharmazie 1993;48(10):772-5.
1984: Antonio M. Rabasco-Alvarez; M Ortega; C Faulí
[Comparative studies of the dissolution kinetics of 2 pharmaceutical forms of isosorbide dinitrate for sublingual administration: capsules and tablets].
Il Farmaco; edizione pratica 1984;39(5):158-69.